NEUROSTIMULATION FOR THE TREATMENT OF PULMONARY DISORDERS

• US 20100217347A1
• Filed: 12/17/2007
• Published: 08/26/2010
• Est. Priority Date: 12/16/2006
• Status: Abandoned Application

• Current Assignee: Greatbatch Limited (Greatbatch Incorporated)
• Original Assignee: Greatbatch Incorporated
• Inventors: Farrell, Richard M., Swoyer, John M.
• Application Number:
  US11/957,710
• Publication Number:
  US 20100217347A1
• Time in Patent Office: Days
• US Class Current: 607/42
• CPC Class Codes: A61B 5/08 Detecting, measuring or recording devices for evaluating the respiratory organs A61B5/0205 takes precedence
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/3601 of respiratory organs

Abstract

Uses of a neurostimulator to treat various conditions including asthma, chronic obstructive pulmonary disease (COPD) and allergies is described. A neurostimulator may be used to modulate neural impulses into and out of the target organs, in this case the bronchi and other airway structures. Stimulation can be used to cause airway dilation and also to inhibit airway constriction.

Claims

1. A pulse generator adapted for delivering a therapy to a body tissue to treat a condition selected from asthma, chronic obstructive pulmonary disease, rhinorrhea, sialorrhea, and allergies.

2. The pulse generator of claim 1 comprising:

a) an electrical power source;

b) a voltage regulator connected to the electrical power source for providing an output voltage;

c) a controller connected to the voltage regulator to provide an output signal; and

d) a driver for generating a desired electrical output from the controller to at least one lead connected to electrodes implanted in a body tissue intended to be treated.

3. The pulse generator of claim 1 wherein the controller is programmed to distinguish between normal respiration and bronchial constriction.

4. The pulse generator of claim 1 wherein the controller regulates at least one of the group consisting of an output signal current, an output voltage, an output signal frequency, an output signal pulse width, an output signal on-time, and an output signal off-time.

5. The pulse generator of claim 1 wherein electrodes are implanted on the vagus nerve in a patient'"'"'s neck.

6. The pulse generator of claim 5 wherein the electrical output is at a voltage ranging from about 5 volts to about 12 volts at a frequency greater than about 50 Hz.

7. The pulse generator of claim 1 wherein electrodes are implanted in the cervical spine or the spinal root.

8. The pulse generator of claim 7 wherein the electrical output is at a voltage ranging from about 5 volts to about 12 volts at a frequency in a range of about 2 Hz to about 20 Hz.

9. The pulse generator of claim 1 wherein the controller is manually activatable by the patient.

10. The pulse generator of claim 9 wherein the manually activatable controller is programmable to a specific patient'"'"'s physiological conditions regarding normal respiration and bronchial constriction.

11. The pulse generator of claim 1 being at least partially external of the body,

12. The pulse generator of claim 1 being implanted in the body.

13. The pulse generator of claim 1 at least partially implanted in a chest of the body.

14. The pulse generator of claim 1 wherein the electrode are either bipolar or multi-polar.

15. The pulse generator of claim 1 wherein the electrodes are implanted on the vagus nerve as it inervates an organ selected from the group consisting of the cervical spinal column, nerve roots from the cervical column and associated ganglia, nerve roots from the thoracic column and associated ganglia, specific nerves at or near the innervation site of the lungs, and specific nerves at or near the innervation site of the bronchi, bronchial ganglion neurons, and combinations thereof.

16. The pulse generator of claim 1 further including an analyzer connected to a detector for processing physiological parameters of the body in response to the delivered therapy.

17. A method for treating a condition selected from asthma, chronic obstructive pulmonary disease, rhinorrhea, sialorrhea, and allergies, the method comprising:

a) providing a closed loop stimulation system, such that the stimulation system is responsive to physiologically originated signals;

b) providing a sensor, that is incorporated into the closed loop stimulation system, such that the sensor detects a change in pleural pressure, that upon detecting an abnormal pressure change, the system automatically turns on stimulation, and then turns the stimulation off when pressure is normalized by emitting the physiologically originated signal; and

c) using the sensor to stimulate a target portion of the nervous system to control dilation of at least one of the lungs and bronchi.

18. The method of claim 17 including stimulating the vagus nerve.

19. The method of claim 17 including providing the stimulation being substantially constant.

20. The method of claim 17 including providing the stimulation being intermittent.

21. The method of claim 17 including providing the stimulation increasing airway dilation.

22. The method of claim 17 including providing the stimulation inhibiting airway constriction.

24. The method of claim 17 including stimulating a target portion of the nervous system selected from the group consisting of:

the cervical spinal column, nerve roots from the cervical column and associated ganglia, nerve roots from the thoracic column and associated ganglia, specific nerves at or near the innervation site of the lungs, and specific nerves at or near the innervation site of the bronchi, bronchial ganglion neurons, and combinations thereof.

25. The method of claim 17 including stimulating efferent nerves to effect airway dilation.

26. The method of claim 17 including stimulating afferent nerves to effect airway dilation or suppression of airway constriction.

27. The method of claim 17 including distinguishing between normal respiration and bronchial constriction.

28. The method of claim 17 including regulating at least one of the group consisting of an output signal current, an output voltage, an output signal frequency, an output signal pulse width, an output signal on-time, and an output signal off-time.

29. The method of claim 17 including implanting electrodes on the vagus nerve in a patient'"'"'s neck as part of the closed loop stimulation system.

30. The method of claim 29 including providing an electrical output ranging from about 5 volts to about 12 volts at a frequency greater than about 50 Hz.

31. The method of claim 17 including implanting electrodes in the cervical spine or the spinal root as part of the closed loop stimulation system.

32. The method of claim 31 including providing an electrical output ranging from about 5 volts to about 12 volts at a frequency in a range of about 2 Hz to about 20 Hz.

36. The method of claim 17 including implanting electrodes as part of the closed loop stimulation system on the vagus nerve as it inervates an organ selected from the group consisting of the cervical spinal column, nerve roots from the cervical column and associated ganglia, nerve roots from the thoracic column and associated ganglia, specific nerves at the innervation site of the lungs, and specific nerves at the innervation site of the bronchi, bronchial ganglion neurons, and combinations thereof.

23. (canceled)

33. (canceled)

34. (canceled)

35. (canceled)